IH
iHuman Inc.
NYSE Consumer Defensive China
1,15 $US
+0.00% today
-42.50% YTD · -61.15% 1Y
0
Insider transactions
SEC Form 4 · AMF · BaFin — rolling 90 days
0
Hedge funds tracked
Latest available SEC 13F filings
55
/ 100
MIXED

Analysis iHuman Inc. (IH) — Kairos Score 55/100

Composite score aggregating 8 smart money dimensions: insiders (SEC/AMF/BaFin), hedge funds, politicians & gurus, price momentum, valuation, analyst consensus, financial health, earnings momentum. The higher the score, the more favorable the institutional signals consensus.

💡 Detailed breakdown (the 8 sub-scores) available in the Premium dashboard.

About iHuman Inc.

iHuman Inc., together with its subsidiaries, provides an integrated suite of tech-powered intellectual development products to individual users, kindergartens, and distributors in the People's Republic of China. The company offers interactive and self-directed apps, including iHuman Chinese, iHuman English, iHuman Pinyin, iHuman Math, iHuman Books, iHuman Stories, iHuman Chinese Classics, iHumanpedia, iHuman Kids Workout, iHuman Coding, iHuman Fun Idioms, iHuman Little Artists, iHuman Readers, iHuman Writing, iHuman Fantastic Friends, iHuman AI Coding, and FreeTalk; bekids Coding, bekids Coloring, bekids Reading, bekids Puzzle, bekids Academy, bekids Library, and the Gogo series; Reading Stars; and Aha World and Aha Makeover. It also provides offline products, such as iHuman AI Pal, a plush AI companion; and the iHuman AI Bilingual Early Learning Tablet, an AI-powered smart learning tablet that delivers a bilingual Chinese-English content library for children. In addition, the company offers intellectually stimulating materials, including books, interactive materials, and smart devices that develop children's abilities in speaking, critical thinking, independent reading, and creativity. Further, it engages in the operation of online applications; provision of management and technical consulting; and research and development activities. iHuman Inc. was founded in 1996 and is based in Beijing, the People's Republic of China.

Key info

👔
CEO
Mr. Peng Dai
📍
HQ
Tower 306, No 86 Beiyuan Road Chaoyang District, Beijing, 100101, China
👥
Employees
558
💰
Market cap
58 274 982,00 $US
📊
P/E
5.3
💸
Dividend yield
—

🕴️ Insider activity (90 days)

0 transactions — 0 buys and 0 sales reported by iHuman Inc. executives.

🏦 Hedge Funds

0 institutional funds report a position on IH in their latest SEC quarterly filing.

📰 Recent news

6 recent articles on IH.

🧠 What makes Kairos Insider

Beyond raw data, we aggregate and score every smart money signal to give you a unique view.

🧠

Kairos Score 0-100

8-dimension composite score: insiders · hedge funds · politicians · momentum · valuation · health · analysts · earnings.

🎯

Insider Clusters

Detection of clustered purchases or sales by several executives in the same stock.

🏦

13F Hedge Funds

Berkshire, Pershing Square, Tiger Global, Bridgewater and other reporting funds.

📈

ETF Rotations

NANC & GOP (Pelosi & Republicans), GURU (top hedge funds), ARK (Cathie Wood). See who enters and exits each week.

🔥

Google Trends

Spot marked changes in search interest around the stocks being followed.

📧

Email alerts

Create your watchlist and receive a brief of events affecting your tickers.

Companies in the same sector as iHuman Inc.

Official sources · Public data · SEC EDGAR — Form 4 & 13F · AMF — Executive filings · BaFin — Directors' Dealings · Yahoo Finance · Alpha Vantage

🔓 Unlock the full analysis

This public page only shows a preview. The full analysis of IH on the Kairos Insider dashboard includes:

✅ Full Kairos Score (8-axis radar + synthesis)
✅ History of all 0 insider transactions over 90 days
✅ All 0 detected institutional funds
✅ Thematic ETFs (ARK, BUZZ, NANC, GOP, JEPI…)
✅ Hot Stocks Google Trends
✅ Available history: AUM + rotations
✅ Fundamentals (P/E, PEG, EV/EBITDA, ROE…)
✅ Financial health (Altman Z, Piotroski F)
✅ Sector peers + recent earnings
See full analysis →
Analyze other tickers for free →

Free signup · Pro €19/month or €190/year